Extract notice to the Minister
Imuldosa (arthrite psoriasique, maladie de Crohn et psoriasis en plaques)
Common name / Subject : ustekinumab
Name of the manufacturer : Accord
Form : Sol. Inj. S.C. (ser)
Dosage : 45 mg / 0,5 ml, 90 mg / 1 ml
Name of the manufacturer : Accord
Form : Sol. Inj. S.C. (ser)
Dosage : 45 mg / 0,5 ml, 90 mg / 1 ml
Indication : Arthrite psoriasique, Maladie de Crohn, Psoriasis en plaques
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
Surseoir à la décision (2026-04-01)
Evaluation published on March 18, 2026
INESSSid: 28038
Recevable on August 04, 2026